Home >

Welcome to ASCO Connection Discussion

LOGIN TO START A DISCUSSION
Molecular Oncology Tumor Board
ASCO University
Dec 07, 2016 8:16 AM
Read more to answer the following questions:
Is further tissue needed to confirm radiologically presumed metastatic disease or for repeat HER2 testing? What systemic therapy option would you recommend for confirmed HER2 negative metastatic gastric cancer?
Molecular Oncology Tumor Board
ASCO University
Nov 09, 2016 11:09 AM
Read more to answer the following questions:

 Recognize the clinical characteristics and outcomes for patients with FLT3 mutations?
Describe the role of FLT3 inhibitors for the initial treatment of AML?
Understand the role of gene mutations, including CLT3,  in the pathologic classification of...
International
ASCO International Affairs
Oct 25, 2016 3:08 PM
The American Society of Clinical Oncology, in collaboration with the Ghana Medical Association, presented a two-day Cancer Control in Primary Care course focused on breast and cervical cancers in Accra, Ghana in September 2016. In addition to lectures, the course included breakout sessions with...
Molecular Oncology Tumor Board
ASCO University
Oct 12, 2016 9:33 AM
Read more to answer the following questions: Who should get routine molecular testing at diagnosis for NSCLC and what tests should be performed? What is the most appropriate initial treatment for this patient?
Research and Meeting News
Virginia D. Anderson
Oct 06, 2016 6:34 PM
The Yale School of Public Health TREC Training Workshop is geared to early-career basic, clinical, and population scientists who are interested in energy balance and cancer research from a transdisciplinary and translational perspective. Seminars...

Pages

Tweets from ASCO

Tweets from Oncology Community